CVS Group plc Annual Results For the year ended 30 June 2017 Simon - - PowerPoint PPT Presentation

cvs group plc
SMART_READER_LITE
LIVE PREVIEW

CVS Group plc Annual Results For the year ended 30 June 2017 Simon - - PowerPoint PPT Presentation

CVS Group plc Annual Results For the year ended 30 June 2017 Simon Innes Chief Executive Officer Nick Perrin Finance Director Prepared for: Agenda Highlights Strategy Business Review - Practices -


slide-1
SLIDE 1

Prepared for:

CVS Group plc

Annual Results For the year ended 30 June 2017

Simon Innes – Chief Executive Officer Nick Perrin – Finance Director

slide-2
SLIDE 2

Agenda

www.cvsukltd.co.uk

2

  • Highlights
  • Strategy
  • Business Review
  • -

Practices

  • -

Laboratories

  • -

Crematoria

  • -

Animed Direct

  • Financial review
  • Outlook
  • Appendices
slide-3
SLIDE 3

Highlights

3

www.cvsukltd.co.uk

Year ended 30 June 2017 Year ended 30 June 2016 Increase %

Revenue (£m) 271.8 218.1 24.6 Adjusted EBITDA (£m) 42.1 32.8 28.2 Adjusted profit before income tax (£m) 33.5 24.9 34.8 Adjusted earnings per share (pence) 42.8 32.4 32.1 Operating profit (£m) 17.2 11.8 46.2 Profit before income tax (£m) 14.5 9.1 58.4 Basic earnings per share (pence) 18.5 11.6 59.5 Proposed dividend (pence) 4.5 3.5 28.6

slide-4
SLIDE 4

Highlights

4

www.cvsukltd.co.uk

Revenue growth up 24.6 % to £271.8m Like-for-like sales +6.3% Adjusted EBITDA up 28.2% to £42.1m Adjusted earnings per share up 32.1% to 42.8p

Acquisitions

Significant number of acquisitions in year:

  • 62 surgeries
  • Including 9 in Holland and 2 in

Northern Ireland This has continued post year end with significant acquisitions including B&W Equine

Referrals

Significant development of referrals business:

  • MVS
  • Chestergates refurbishment

Other

  • Greenfield site opened in

Smethwick

  • £29.6m raised through equity

placing

  • Healthy Pet Club (HPC)

members up 20.9% to 306,000

  • MiPet Cover Insurance

launched in July 2017

167.3 218.1 271.8 100 200 300 2015 2016 2017 £m

Sales

23.0 32.8 42.1 10 20 30 40 50 2015 2016 2017 £m

Adjusted EBITDA

24.7 32.4 42.8 20 40 60 2015 2016 2017 Pence per share

Adjusted earning per share

slide-5
SLIDE 5

Highlights

5

www.cvsukltd.co.uk

Industry update

CVS owns 432 surgeries and is the largest integrated provider of veterinary services to animal owners in the UK and the Netherlands.

CVS Vets4 Pets IVC Medivet Goddards Vets Now August Sovereign Surgeries 432 444 440 199 49 3 181 54 Referral sites* 7 4 5 3 1 4 Laboratories 4 1 1 1 Crematoria 7 11 Dedicated

  • ut-of-hours*

14 56 Buying group 2 Instruments business 1 On-line 1 1 1

Most surgeries are small animal only, except for CVS and August. *Included within surgeries

slide-6
SLIDE 6

Strategy

6

www.cvsukltd.co.uk

Vision To continue to be the largest & most comprehensive provider of veterinary services to animal

  • wners in the UK whilst delivering a growing return to our shareholders.

Meeting all our customers’ needs High quality clinical care and excellent customer service Providing services to other veterinary practices Expanding our business through acquisitions

slide-7
SLIDE 7

Business review - Results by division

7

www.cvsukltd.co.uk

Four main business areas

  • Veterinary practices
  • Diagnostic laboratories
  • Pet crematoria
  • Animed Direct online dispensary

Turnover by business area £m (before intra-group eliminations) % of Revenue per Business Area Practices Laboratories Crematoria Animed Direct 2017 87.4% 5.7% 2.3% 4.6% 2016 86.9% 6.6% 2.2% 4.3% 2015 85.0% 7.6% 1.5% 5.9%

The above reflects sales prior to the inter-company elimination between the practice division and other divisions.

247.9 16.3 6.3 13.0 Practices Laboratories Crematoria Animed Direct

slide-8
SLIDE 8

Results by division

8

www.cvsukltd.co.uk

Year ended 30 June 2017 Practices Laboratories Crematoria Animed Direct Head Office Group

Revenue (£m) 247.9 16.3 6.3 13.0 (11.7) 271.8 EBITDA (£m) 44.7 3.6 2.1 0.7 (9.0) 42.1 Gross margin after materials % 80.1 65.4 81.7 17.4

  • 79.7

EBITDA % 18.0 22.4 32.7 5.6

  • 15.5

Year ended 30 June 2016 *Restated Practices Laboratories Crematoria *Restated Animed Direct Head Office Group

Revenue (£m) 198.1 14.8 5.0 8.4 (8.2) 218.1 EBITDA (£m) 35.6 3.1 1.7 0.3 (7.9) 32.8 Gross margin after materials %* 79.8 66.2 80.6 20.8

  • 79.6

EBITDA % 18.1 20.9 34.2 3.2

  • 15.0

* The prior year comparatives have been restated to reflect the reclassification of the Group’s logistics and warehousing operations from Animed Direct to the Veterinary Practice Division. Revenue in the Animed Division decreased by £1.4m and there was a corresponding increase in the revenue of the Veterinary Practice Division. Divisional EBITDA was unaffected by the change. The reclassification had no impact on Group revenue.

slide-9
SLIDE 9

www.cvsukltd.co.uk

9

Business review - Veterinary Practices

Practice revenue split

2017 £m 2016 £m Like-for-like revenue 182.8 172.2 2016 acquisitions 51.7 25.9 2017 acquisitions 13.4

  • Total revenue

247.9 198.1

Like-for-like sales +5.2%

20.2 21.9 25.3 35.6 44.7 10 20 30 40 50 2013 2014 2015 2016 2017

5 year EBITDA £m

108.0 126.4 147.5 198.1 247.9 50 100 150 200 250 300 2013 2014 2015 2016 2017

5 Year revenue £m

slide-10
SLIDE 10

Business review – Veterinary Practices

10

www.cvsukltd.co.uk

Acquisitions during the year Location Business

GB Practices: Severn Edge Group Shropshire Small, farm animal & equine Deveron Aberdeenshire Small & farm animal Forrest House North Yorkshire Small & farm animal Bell Equine Kent Equine Nottingham Vet Care Nottinghamshire Small animal Buttercross Nottinghamshire Small animal Church Walk Cumbria Small animal Batheastern Somerset Small animal Haven Norfolk Small animal Valley Vets Ayrshire Small animal Pennine Lancashire Small animal Ambivet Derbyshire & Nottinghamshire Small animal Smethwick (Green field) West Midlands Small animal

432 surgeries across the UK and the Netherlands - 62 surgeries acquired in the year in the following locations:

Acquisitions during the year Location Business

Willow Norfolk Small animal Champion Glasgow & Falkirk Small animal Eagle Suffolk Small animal Animed Whitstable Kent Small animal Phoenix Vets Surrey & Berkshire Small animal Shannon Lodge Nottinghamshire Small animal Medina Isle of Wight Small animal Northern Ireland Practices: O’Reilly & Fee County Armagh, NI Small & farm animal All Creatures Veterinary Healthcare Limavady, NI Small animal

slide-11
SLIDE 11

www.cvsukltd.co.uk

11

Business review - Veterinary Practices

10 surgeries acquired post year end in the following locations:

Acquisitions after the year end Location Business

Cundall & Duffy Scarborough Small & farm animal Strule Vet Services Omagh and County Tyrone, Northern Ireland Small & farm animal Dierienkliniek Wolvega Wolvega, Netherlands Small animal B & W Equine Breadstone, Cardiff, Failand, Stretcholt and Willesley Equine Aire Leeds Small animal

Acquisitions during the year Location Business

Dutch practices: Dierenziekenhuis Drachten Drachten, NL Small animal Kliniek voor Gezelschapsdieren Dieren Dieren, NL Small animal Dierenartsenpraktijk Zuid-West Friesland Lemmer NL, Emmeloord NL Small & farm animal & equine Radis Veterinary Group Zwolle NL, Hengelo NL, Amersfoort NL Small animal

slide-12
SLIDE 12

Business review – Veterinary Practices

12

www.cvsukltd.co.uk

Referrals

  • Significant development of the referrals network:

– Lumbry Park in Alton, significantly improved in second half of the year. – MVS opened in February 2017 and trading well – Chestergates refurbishment completed in 2017. CT scanner and new MRI scanner.

  • 46 diploma holders now at CVS with a wide range of

specialisms

slide-13
SLIDE 13

Business review – Veterinary Practices

13

www.cvsukltd.co.uk

Own Brand

  • High quality products
  • Distributed by CVS Logistics
  • Now have 15 own brand medicines representing 25% of practice spend
  • Lower prices and better margins
  • Own brand pet food now 32% of total life-stage practice sales

Out-of-hours

  • 14 established dedicated emergency out-of-hours centres
  • Planning to open another out-of-hours centre in 2018

Healthy Pet Club

  • Over 20% increase in membership to 306,000
  • At end August 2017 membership was just over 317,000
  • HPC revenue

– All practices – 13.4% of total revenue (2016: 12.3%) – Like-for-like practices – 16.9% (2016: 13.7%)

  • Healthy Horse Programme relaunched.
slide-14
SLIDE 14

Business review – Veterinary Practices - Buying Group

14

www.cvsukltd.co.uk

www. www.mive ivetcl club.co.uk www.vetshar hare.c .co.u

  • .uk

MiVetClub VetShare

Member sites 10 396 Restricted to CVS dedicated & preferred goods Yes No Wholesaler NVS and Henry Schein Any CVS own brand products available Yes Yes Use of laboratories offered CVS CVS, Idexx, NWL Use of crematoria offered CVS CVS, PCS Other services from CVS Training, H&S, MiHealthyPet, Discount from VETisco MiHealthyPet, Discount from VETisco

slide-15
SLIDE 15

www.cvsukltd.co.uk

15

Business review – Veterinary Practices

  • Training

New Graduate Programme

  • 375 graduates have gone through the scheme in the past three years.
  • Designed to assist newly qualified vets make the challenging transition from university to day-to-day practice.

Advanced Practitioner Programme

  • 136 vets have been put through this programme.

MiNurse Academy

  • In house clinical training program – launched January 2015.
  • Now over 300 nurses learning specialist skills since launch.
  • The academy provides nurses with advanced training in one of four areas: medicine, surgery, emergency and

critical care, and clinical nursing.

  • Designed to fill a gap which exists across the profession in the post-qualification training of nurses.

Leadership programmes

  • Aspire – 6 day management programme for practice managers – 22 people went through this programme this

year.

  • Leap – 6 day management programme for managers – 34 people went through this programme this year.
slide-16
SLIDE 16

Business review – Veterinary Practices - Careers

16

www.cvsukltd.co.uk

  • Larger group gives

enhanced opportunities

  • Careers that are new to

the whole veterinary industry

  • Careers suitable for part-

time workers

  • Roles for small animal,

large animal and equine

slide-17
SLIDE 17

Business review –

17

www.cvsukltd.co.uk

  • Designed by vets
  • Launched July 2017
  • Well received by staff
  • Initial customer response is promising
  • High quality, good value, easy to

understand

  • CVS not underwriting
slide-18
SLIDE 18

www.cvsukltd.co.uk

18

Business review – Laboratories

  • Revenue growth of 10.2% to

£16.3m (all like-for-like)

  • EBITDA improved to

£3.6m (2016: £3.1m)

9.1 10.6 13.1 14.8 16.3 2 4 6 8 10 12 14 16 18 2013 2014 2015 2016 2017

£m

5 year revenue £m

1.1 1.1 2.2 3.1 3.6 0.5 1 1.5 2 2.5 3 3.5 4 2013 2014 2015 2016 2017

£m

5 year EBITDA £m

slide-19
SLIDE 19

Business review – Laboratories

19

www.cvsukltd.co.uk

  • Analyser business growing steadily
  • Some increase in price pressures on diagnostics business
  • Internal partnering with Bell on Equine testing.
  • Our laboratory (Axiom) that deals with large animal work achieved ISO 17025 accreditation in

March 2017 – as a result, farm diagnostics will be an area of growth for this division

  • PCR testing now profitable

324,000 354,000 368,000 380,000 405,000 50000 100000 150000 200000 250000 300000 350000 400000 450000 2013 2014 2015 2016 2017

Number of tests performed

30% 70%

Internal vs external sales

Internal sales External sales

slide-20
SLIDE 20

www.cvsukltd.co.uk

20

Business review – Crematoria

1.0 1.6 2.6 5.0 6.3 0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 2013 2014 2015 2016 2017

5 year revenue £m

0.4 0.4 0.8 1.7 2.1 0.5 1 1.5 2 2.5 2013 2014 2015 2016 2017

5 year EBITDA £m Crematoria revenue split

2017 £m 2016 £m Like-for-like revenue 4.4 3.9 Acquisitions 1.9 1.1 Total revenue 6.3 5.0

Like-for-like sales +14.4%

slide-21
SLIDE 21

Business review – Crematoria

21

www.cvsukltd.co.uk

35,000 44,000 68,000 118,000 143,000 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 2013 2014 2015 2016 2017

Number of cremations

50.4% 49.6% External sales Internal sales

The Crematoria Division Coverage Map

slide-22
SLIDE 22

www.cvsukltd.co.uk

22

Business review – Animed Direct

  • New management in place
  • Significant recovery of sales
  • Further development of website planned
  • Moved to larger warehouse
  • Delivery fee was introduced in May 2017

and free delivery threshold in the second half of the year. 2017 2016 Number of product lines

4,240 3,500

Monthly website visits

237,000 160,000

Average order value

£38.00 £31.00

No of customers

410,000 335,000

Revenues increased by 53.6% to £13.0m Adjusted EBITDA rose to £0.7m

0.1 0.3 0.5 0.3 0.7 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 2013 2014 2015 2016 2017 £m

Animed Direct EBITDA £m

4.9 8.5 10.3 8.4 13.0 2 4 6 8 10 12 14 2013 2014 2015 2016 2017 £m

Animed Direct revenue £m

slide-23
SLIDE 23

www.cvsukltd.co.uk

23

Business review – Head Office

  • Costs 3.3% of sales compared to 3.6% in

the prior year

  • General increase in staffing levels

– Reflecting business growth – To maintain control of acquisitions

  • Internal audit function commenced
  • Additional Head Office building acquired
slide-24
SLIDE 24

Financial results – Profit & Loss

24

www.cvsukltd.co.uk

Year ended 30 June 2017 Restated* Year ended 30 June 2016 £m £m

Revenue 271.8 218.1 Cost of sales (147.3) (112.2) Gross profit 124.5 105.9 Administrative expenses (107.3) (94.1) Operating profit 17.2 11.8 Net finance expenses (2.7) (2.7) Profit before income tax 14.5 9.1 Income tax expense (3.0) (2.1) Profit after income tax 11.5 7.0 Earnings per ordinary share

  • Basic

18.5p 11.6p

  • Adjusted

42.8p 32.4p Dividend 4.5p 3.5p

* The prior year comparatives have been restated to reflect the reclassification of the Group’s logistics and warehousing operations from Animed Direct to the Veterinary Practice Division. Revenue in the Animed Division decreased by £1.4m and there was a corresponding increase in the revenue of the Veterinary Practice Division. Divisional EBITDA was unaffected by the change. The reclassification had no impact on Group revenue.

slide-25
SLIDE 25

Financial results – Balance Sheet

25

www.cvsukltd.co.uk

30 June 2017 £m Restated * 30 June 2016 £m Non-current assets Intangible assets 167.2 131.5 Property, plant and equipment 43.0 32.8 Investments 0.1 0.1 Deferred income tax assets 2.1 1.8 Derivative financial instruments 0.1

  • 212.5

166.2 Current assets Inventories 12.5 9.7 Trade and other receivables 30.9 23.8 Cash and cash equivalents 6.8 6.7 50.2 40.2 Total assets 262.7 206.4 Current liabilities Trade and other payables (48.2) (43.0) Current income tax liabilities (2.9) (2.3) Borrowings (3.3) (0.3) (54.4) (45.6) Non-current liabilities Borrowings (103.5) (99.5) Deferred income tax liabilities (16.8) (14.6) Derivative financial instruments

  • (0.1)

(120.3) (114.2) Total liabilities (174.7) (159.8) Net assets 88.0 46.6

*Management has elected to change its accounting policy in relation to the classification of its revolving credit facility (“RCF”) to reflect management’s intention in relation to repayment rather than solely the legal form of the arrangement. The impact of this is that the £37.0m (2016: £30.5m) RCF has been disclosed as a non current liability. This change has also been reflected retrospectively to adjust the classification of the RCF from current liabilities to non current liabilities in the prior periods. This change in accounting policy has no impact on the income statement, earnings per share or any other key performance indicator.

slide-26
SLIDE 26

Financial results – Change in Debt

26

www.cvsukltd.co.uk Year ended 30 June 2017 £m Year ended 30 June 2016 £m Cash generated from operations 37.2 33.6 Taxation paid (5.4) (3.3) Net interest paid (2.1) (2.4) Capital expenditure - maintenance (5.9) (5.1) Free cash flow 23.8 22.8 Capital expenditure - development (7.9) (6.4) Acquisitions (48.4) (61.3) Dividend paid (2.1) (1.8) Proceeds from issue of Ordinary shares 30.6 0.2 Purchase of own shares (2.1)

  • Debt issuance costs movement

(0.8) (0.4) Increase in net debt (6.9) (46.9)

slide-27
SLIDE 27

Financial results – Capital Expenditure

27

www.cvsukltd.co.uk

Total capital expenditure in the year amounted to £13.8m

New sites & relocations:

  • Smethwick
  • Stechford/Sheldon
  • Gorleston
  • West Vale
  • Holywell House

Major refurbishments:

  • Chestergates
  • Pet Medics & MVS

3.0 4.9

Fixed assets - Development expenditure £7.9m

Major refurbishments New sites 2.2 3.3 0.4

Fixed assets - Maintenance expenditure £5.9m

Large equipment Improving and maintaining equipment IT systems development

slide-28
SLIDE 28

Financial results – Net Debt

28

www.cvsukltd.co.uk

  • Facility extended in July 2017 to allow high level of

larger acquisitions

  • Total available facilities:

£67.5m term loan to Nov 2021 £85.0m RCF to Nov 2021 £5.0m overdraft

  • Syndicated facility (RBS, HSBC, AIB)
  • Margins – increased by 0.5%
  • Leverage covenant (Net debt / EBITDA *):

3.5 to Dec 2017 3.0 thereafter

  • EBITDA : Interest covenant 4.5
  • Borrowing increased due to £48.5m spent on acquisitions
  • Net debt: EBITDA ratio at 2.3, down from 2.54 at June

2016

*Trailing 12-month EBITDA, annualised for impact of acquisitions

30.0 31.3 46.2 93.1 100.0 0.0 20.0 40.0 60.0 80.0 100.0 120.0 Jun-13 Jun-14 Jun-15 Jun-16 Jun-17 £m

Net debt

1.90 1.71 2.01 2.92 2.54 1.67 2.30 1.00 1.50 2.00 2.50 3.00 3.50 Jun-13 Dec-13 Jun-14 Dec-14 Jun-15 Dec-15 Jun-16 Dec-16 Jun-17 Ratio

Net debt: EBITDA

slide-29
SLIDE 29

www.cvsukltd.co.uk

29

Outlook

Existing Business

  • Like-for-like sales continuing at more normal levels since the year end
  • Referral services: development of MVS, Lumbry Park, Chestergates
  • Development of new sites – Smethwick, Norwich, Bracknell
  • Own brand products: further drugs to be added
  • Out-of-hours centres development
  • Animed Direct: further website improvements
  • MiPet Cover

Growth through selective acquisitions

  • Acquisition pipeline remains strong
  • Large opportunity in small animal sector, large animal and equine sector – in UK & The Netherlands

Finance

  • Strong cash flow and healthy balance sheet
  • Further investment in core business activities
slide-30
SLIDE 30

Appendices

slide-31
SLIDE 31

Overview

31

www.cvsukltd.co.uk

  • UK’s largest integrated provider

and consolidator of veterinary practices

  • Market leader, making CVS the

acquirer of choice

  • Consistent growth in a more

challenging environment

  • Complementary businesses to

internalise margins and maximise revenues

5,150 Employees 1,270 Vets 432 Surgeries nationwide 4 Diagnostics laboratories 7 Crematoria 1 On-line dispensary

slide-32
SLIDE 32

EBITDA & Gross Margin Trends

32

www.cvsukltd.co.uk

Year ended 30 June 2015 2016 2017 £m £m £m Revenue 167.3 218.1 271.8 EBITDA 23.0 32.8 42.1 % of sales % % % Gross margin after materials

  • Group

55.4 79.6 79.7

  • Practices *

88.0 79.8 80.1

  • Animed Direct *

17.9 20.8 17.4

  • Laboratories *

71.0 66.5 65.4

  • Crematorium

79.3 80.6 81.7 Central administration 3.6 3.6 3.3 EBITDA margin (%) 14.4 15.1 15.5

* The prior year comparatives have been restated to reflect the reclassification of the Group’s logistics and warehousing operations from Animed Direct to the Veterinary Practice Division. Revenue in the Animed Division decreased by £1.4m and there was a corresponding increase in the revenue

  • f the Veterinary Practice Division. Divisional

EBITDA was unaffected by the change. The reclassification had no impact on Group revenue.

slide-33
SLIDE 33

Cash Generated from Operations

33

www.cvsukltd.co.uk Year ended 30 June 2017 £m Year ended 30 June 2016 £m Profit for the year 11.5 7.0 Taxation 3.0 2.1 Total finance costs 2.7 2.7 Amortisation of intangible assets 16.0 13.7 Depreciation of property, plant and equipment 5.9 5.2 (Increase) in inventories (1.5) (1.6) Decrease/(Increase) in trade and other receivables (4.5) 5.2 (Decrease)/increase in trade and other payables 2.6 (2.0) Share option expense 1.5 1.3 Total cash flows from operating activities 37.2 33.6

slide-34
SLIDE 34

Adjusted items definitions

34

www.cvsukltd.co.uk

  • Adjusted EBITDA is profit before income tax, net

finance expense, depreciation, amortisation, costs relating to business combinations and exceptional items.

  • Adjusted profit before income tax is calculated as

profit on ordinary activities before amortisation, taxation, costs relating to business combinations and exceptional items.

  • Adjusted earnings per share is calculated as

adjusted profit before income taxation divided by the weighted average number of ordinary shares in issue in the year.

slide-35
SLIDE 35

Thank you

Any questions?

Contact us

CVS Group plc CVS House Owen Road Diss Norfolk IP22 4ER Tel: 01379 644288

Any questions?